IRIS Accounts Production v23.2.0.158 06239926 director 24.11.21 23.11.22 23.11.22 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh062399262021-11-23062399262022-11-23062399262021-11-242022-11-23062399262020-11-23062399262020-11-242021-11-23062399262021-11-2306239926ns10:Originalns15:EnglandWales2021-11-242022-11-2306239926ns14:PoundSterlingns10:Original2021-11-242022-11-2306239926ns10:Originalns10:Director12021-11-242022-11-2306239926ns10:Original2021-11-242022-11-2306239926ns10:Original2022-11-2306239926ns10:Originalns10:PrivateLimitedCompanyLtd2021-11-242022-11-2306239926ns10:Originalns10:SmallEntities2021-11-242022-11-2306239926ns10:Originalns10:AuditExemptWithAccountantsReport2021-11-242022-11-2306239926ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2021-11-242022-11-2306239926ns10:SmallCompaniesRegimeForAccountsns10:Original2021-11-242022-11-2306239926ns10:Originalns10:FullAccounts2021-11-242022-11-2306239926ns10:CompanySecretary1ns10:Original2021-11-242022-11-2306239926ns10:Originalns10:RegisteredOffice2021-11-242022-11-2306239926ns10:Original2021-11-2306239926ns10:Originalns5:CurrentFinancialInstruments2022-11-2306239926ns10:Originalns5:CurrentFinancialInstruments2021-11-2306239926ns5:ShareCapitalns10:Original2022-11-2306239926ns5:ShareCapitalns10:Original2021-11-2306239926ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-11-2306239926ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-11-2306239926ns10:Originalns5:PlantMachinery2021-11-242022-11-2306239926ns10:Original2020-11-242021-11-2306239926ns10:Originalns5:PlantMachinery2021-11-2306239926ns10:Originalns5:PlantMachinery2022-11-2306239926ns10:Originalns5:PlantMachinery2021-11-2306239926ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-2306239926ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2021-11-2306239926ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-11-2306239926ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-11-242022-11-2306239926ns10:Original1ns10:Director12021-11-2306239926ns10:Original1ns10:Director12020-11-2306239926ns10:Original1ns10:Director12021-11-242022-11-2306239926ns10:Original1ns10:Director12020-11-242021-11-2306239926ns10:Original1ns10:Director12022-11-2306239926ns10:Original1ns10:Director12021-11-23
REGISTERED NUMBER: 06239926 (England and Wales)



Financial Statements for the Year Ended 23 November 2022

for

Materia Medica International Limited

Materia Medica International Limited (Registered number: 06239926)

Contents of the Financial Statements
for the Year Ended 23 November 2022










Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 6

Report of the Accountants 7

Materia Medica International Limited

Company Information
for the Year Ended 23 November 2022







DIRECTOR: Dr M J Bowles





SECRETARY: Mrs T Bowles





REGISTERED OFFICE: Musings Oast
Darwell Hill
Netherfield
Battle
East Sussex
TN33 9QL





REGISTERED NUMBER: 06239926 (England and Wales)





ACCOUNTANTS: BBK Partnership
Chartered Accountants
& Statutory Auditors
1 Beauchamp Court
10 Victors Way
Barnet
Hertfordshire
EN5 5TZ

Materia Medica International Limited (Registered number: 06239926)

Balance Sheet
23 November 2022

23.11.22 23.11.21
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,964 1,277

CURRENT ASSETS
Stocks 9,625 -
Debtors 5 15,858 15,670
Cash at bank 9,479 48,006
34,962 63,676
CREDITORS
Amounts falling due within one year 6 (74,973 ) (54,210 )
NET CURRENT (LIABILITIES)/ASSETS (40,011 ) 9,466
TOTAL ASSETS LESS CURRENT
LIABILITIES

(38,047

)

10,743

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 7 (38,147 ) 10,643
(38,047 ) 10,743

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 23 November 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 23 November 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Materia Medica International Limited (Registered number: 06239926)

Balance Sheet - continued
23 November 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 19 October 2023 and were signed by:





Dr M J Bowles - Director


Materia Medica International Limited (Registered number: 06239926)

Notes to the Financial Statements
for the Year Ended 23 November 2022


1. STATUTORY INFORMATION

Materia Medica International Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance to improvements, 20% on reducing balance and not provided

Stocks
Work in progress is valued at the lower of cost and net realisable value.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2021 - 2 ) .

Materia Medica International Limited (Registered number: 06239926)

Notes to the Financial Statements - continued
for the Year Ended 23 November 2022


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 24 November 2021 43,294
Additions 1,217
At 23 November 2022 44,511
DEPRECIATION
At 24 November 2021 42,017
Charge for year 530
At 23 November 2022 42,547
NET BOOK VALUE
At 23 November 2022 1,964
At 23 November 2021 1,277

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
23.11.22 23.11.21
£    £   
Trade debtors - 10,260
Other debtors 15,858 5,410
15,858 15,670

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
23.11.22 23.11.21
£    £   
Trade creditors - 10,245
Taxation and social security 65,963 36,815
Other creditors 9,010 7,150
74,973 54,210

7. RESERVES
Retained
earnings
£   

At 24 November 2021 10,643
Deficit for the year (48,790 )
At 23 November 2022 (38,147 )

Materia Medica International Limited (Registered number: 06239926)

Notes to the Financial Statements - continued
for the Year Ended 23 November 2022


8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 23 November 2022 and 23 November 2021:

23.11.22 23.11.21
£    £   
Dr M J Bowles
Balance outstanding at start of year 4,165 -
Amounts advanced 11,692 4,165
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 15,857 4,165

Materia Medica International Limited

Report of the Accountants to the Director of
Materia Medica International Limited


The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 23 November 2022 set out on pages three to seven and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






BBK Partnership
Chartered Accountants
& Statutory Auditors
1 Beauchamp Court
10 Victors Way
Barnet
Hertfordshire
EN5 5TZ


Date: .............................................